GO:1901970 positive regulation of mitotic sister chromatid separation: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901970 describes any process that activates or increases the frequency, rate or extent of mitotic sister chromatid separation, a critical step ensuring faithful chromosome segregation.
• The core molecular event is the proteolytic cleavage of cohesin by separase, which is positively regulated by phosphorylation and by the cohesin-releasing network.
• Key positive regulators include separase (ESPL1), Polo-like kinase 1 (PLK1), and Cdk1-cyclin B1, which phosphorylate and activate components of the separation machinery.
• Dysregulation of this process leads to aneuploidy and is implicated in cancers such as BCR-ABL-positive leukemia and multiple solid tumors.
• Research models for this term span knockout, point-mutation, knock-in, and overexpression cell lines, often combined with live-cell imaging and proteomics.
• EDITGENE provides CRISPR-based services to dissect the causal roles of genes in positive regulation of mitotic sister chromatid separation.
Description
Mitotic sister chromatid separation is the final irreversible step of mitosis, ensuring that each daughter cell receives an identical copy of the genome. The Gene Ontology term GO:1901970, positive regulation of mitotic sister chromatid separation, encompasses all processes that activate or increase the frequency, rate, or extent of this separation event. This regulation is essential for genomic stability, and its failure can lead to aneuploidy, a hallmark of cancer and developmental disorders. Researchers study this term to understand how cells temporally and spatially control cohesin removal and separase activity, and to identify therapeutic targets in diseases characterized by chromosome mis-segregation. The process is highly conserved from yeast to humans, with key regulators such as separase, Polo-like kinase, and Cdk1-cyclin B1 coordinating the dissolution of sister chromatid cohesion.
positive regulation of mitotic sister chromatid separation At A Glance
| GO ID | GO:1901970 |
|---|---|
| GO term | positive regulation of mitotic sister chromatid separation |
| Ontology | biological_process |
| Synonym | activation of mitotic sister chromatid separation; upregulation of sister chromatid separation during mitosis; positive regulation of mitotic chromosome separation |
| Major function | Activates or increases the frequency, rate or extent of mitotic sister chromatid separation, ensuring faithful chromosome segregation. |
| Key regulators | Separase (ESPL1), Polo-like kinase 1 (PLK1), Cdk1-cyclin B1, and components of the cohesin-releasing network. |
| Associated cellular structures | Mitotic spindle, kinetochores, cohesin complexes, and centromeric chromatin. |
| Disease relevance | Aneuploidy, cancer (e.g., BCR-ABL-positive leukemia, multiple solid tumors), and developmental abnormalities. |
What Is GO:1901970?
GO:1901970 is defined as any process that activates or increases the frequency, rate or extent of mitotic sister chromatid separation. In other words, it covers the positive regulatory inputs—biochemical signals, protein modifications, and protein-protein interactions—that promote the timely and efficient splitting of sister chromatids during mitosis, as opposed to the structural components of the chromatids themselves or the separation process per se.
Why Is positive regulation of mitotic sister chromatid separation Important in Cell Biology?
Positive regulation of mitotic sister chromatid separation is fundamental to genome stability. Without proper activation of separase and dissolution of cohesin, sister chromatids fail to separate, leading to aneuploidy, cell cycle arrest, or cell death. This process is tightly regulated by phosphorylation and proteolysis, and its dysregulation is directly linked to tumorigenesis and cancer progression. Understanding the positive regulators provides insights into basic cell cycle control and offers potential targets for anticancer therapies, particularly in leukemias and solid tumors where mitotic regulators are aberrantly activated.
• Ensures faithful chromosome segregation and prevents aneuploidy.
• Dysregulation is a hallmark of many cancers, including BCR-ABL-positive leukemia.
• Separase activity is increased by imatinib in BCR-ABL-positive cells, linking therapy to mitotic regulation.
• SPAG5, a mitotic regulator, is a prognostic biomarker across multiple cancers.
• Polo-like kinase 1 (PLK1) is a key positive regulator and a target for cancer therapy.
• Cdk1-cyclin B1 phosphorylates and regulates separase, providing a link to cell cycle checkpoints.
• Cohesin-dependent regulation of Runx genes connects sister chromatid separation to transcription and development.
• PKCε-regulated pathways monitor and resolve mitotic catenation, a related process.
• Yeast genetic interactions reveal conserved roles for cohesin, PKA, CDK, and APC in separation.
• Experimental models using CRISPR can dissect causal roles of individual regulators in this process.
What Happens During positive regulation of mitotic sister chromatid separation?
Activation of Separase by Phosphorylation and Proteolysis
In simple terms: Separase is the enzyme that cuts the cohesin rings holding sister chromatids together; it must be switched on at the right time.
Separase (ESPL1) is a cysteine protease that cleaves the Scc1/Rad21 subunit of the cohesin complex, allowing sister chromatids to separate. Its activity is positively regulated by phosphorylation. In vertebrates, Cdk1-cyclin B1 phosphorylates separase at multiple sites, which can both activate and inhibit its protease activity, providing a dual regulatory mechanism that may explain why securin is dispensable in some contexts. Polo-like kinase 1 (PLK1) also promotes separase activation indirectly by phosphorylating and targeting securin for degradation, and by phosphorylating other components of the separation machinery. Thus, the positive regulation of sister chromatid separation involves a kinase cascade that ultimately triggers cohesin cleavage.
Cohesin Releasing Network and Chromosome Resolution
In simple terms: A network of proteins removes the cohesin glue from chromosomes in a stepwise manner.
Sister chromatid resolution is mediated by a cohesin-releasing network that includes Wapl, Pds5, and other factors. Positive regulation of separation involves the activation of this network, which removes the bulk of cohesin from chromosome arms during prophase, while centromeric cohesin is protected until anaphase. This two-step process ensures that chromatids are resolved but remain connected until the spindle checkpoint is satisfied. The network is regulated by phosphorylation events, including those mediated by PLK1 and Cdk1, which modulate the interaction between cohesin and its release factors.
Spindle Assembly Checkpoint and Anaphase Onset
In simple terms: The cell waits until all chromosomes are properly attached before giving the go-ahead for separation.
The spindle assembly checkpoint (SAC) monitors kinetochore-microtubule attachments and inhibits the anaphase-promoting complex/cyclosome (APC/C) until all chromosomes are bioriented. Positive regulation of sister chromatid separation is coupled to SAC satisfaction because APC/C activation leads to securin degradation and separase activation. In budding yeast, genetic interactions between cohesin and APC components highlight the conserved link between checkpoint control and cohesin cleavage. Thus, positive regulators include not only the enzymatic machinery but also the signaling pathways that time their activation.
Mitotic Catenation and Topological Resolution
In simple terms: Even after cohesin is removed, DNA strands can remain interlinked and need to be untangled.
Mitotic catenation refers to the interlinking of sister DNA molecules that must be resolved before full separation. A PKCε-regulated pathway monitors and resolves catenation, and its dysfunction can lead to chromosome bridges and breakage. Positive regulation of sister chromatid separation therefore also encompasses the activation of topoisomerase II and other factors that resolve catenanes, ensuring that chromatids can physically move apart. This step is critical for preventing aneuploidy and is coordinated with cohesin removal.
Key Genes Involved in GO:1901970 positive regulation of mitotic sister chromatid separation
The following genes and proteins are central to the positive regulation of mitotic sister chromatid separation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ESPL1 (Separase) | Cleaves cohesin subunit Rad21/Scc1 to allow sister chromatid separation | Core protease; target for cancer therapy; regulated by phosphorylation |
| PLK1 | Phosphorylates securin and other mitotic substrates to promote separase activation | Key positive regulator; inhibitor targets in cancer |
| CDK1 | Forms Cdk1-cyclin B1 complex that phosphorylates separase and cohesin regulators | Cell cycle kinase; dual role in separase regulation |
| CCNB1 (Cyclin B1) | Regulatory subunit of Cdk1; controls mitotic entry and progression | Essential for Cdk1 activity; target for cell cycle studies |
| RAD21 | Cohesin subunit cleaved by separase; maintains sister chromatid cohesion | Substrate of separase; mutations linked to cohesinopathies |
| WAPL | Cohesin release factor; promotes cohesin removal from chromosome arms | Part of cohesin-releasing network |
| PDS5A/PDS5B | Cohesin-associated proteins that modulate release and cohesion | Regulators of cohesin dynamics |
| SPAG5 | Mitotic spindle-associated protein; regulates chromosome segregation | Prognostic biomarker in multiple cancers |
| PKCε (PRKCE) | Kinase involved in resolving mitotic catenation | Regulates topological resolution of sister chromatids |
| APC/C subunits | Ubiquitin ligase that targets securin for degradation | Links checkpoint to separase activation |
| PKA subunits | Yeast protein kinase A; genetically interacts with cohesin | Conserved regulation of cohesin function |
| SCC1/MCD1/RHC21 | Yeast cohesin subunit; interacts with PKA, CDK, APC | Model for cohesin regulation |
| RUNX1 | Transcription factor regulated by cohesin; affects differentiation | Cohesin-dependent regulation links to leukemia |
| RUNX2 | Transcription factor regulated by cohesin; affects osteogenesis | Cohesin-dependent regulation |
| RUNX3 | Transcription factor regulated by cohesin; affects neurogenesis | Cohesin-dependent regulation |
| Topoisomerase II (TOP2A) | Resolves DNA catenanes during mitosis | Required for sister chromatid separation |
| Aurora B kinase | Regulates chromosome bi-orientation and checkpoint | Indirect positive regulator of separation |
| MAD2 | Spindle assembly checkpoint protein; delays anaphase until attachment | Regulates timing of separase activation |
How Is positive regulation of mitotic sister chromatid separation Regulated?
The positive regulation of mitotic sister chromatid separation is controlled by phosphorylation and ubiquitin-mediated proteolysis. Cdk1-cyclin B1 phosphorylates separase, which can both activate and inhibit its protease activity, suggesting a complex regulatory balance. Polo-like kinase 1 (PLK1) promotes securin degradation and phosphorylates other mitotic substrates to drive separation. The APC/C ubiquitin ligase targets securin for degradation, releasing separase. Additionally, the cohesin-releasing network is regulated by phosphorylation of Wapl and Pds5. In budding yeast, genetic interactions between cohesin and PKA, CDK, and APC highlight conserved regulatory inputs. PKCε regulates the resolution of mitotic catenation, a process that must be coordinated with cohesin cleavage.
positive regulation of mitotic sister chromatid separation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ESPL1 | BCR-ABL-positive leukemia; increased separase activity with imatinib | Knockout or point-mutation in K562 cells; measure separase activity |
| SPAG5 | Multiple cancers; prognostic biomarker | Overexpression and knockout in cancer cell lines; proliferation assays |
| PLK1 | Various cancers; mitotic kinase target | Knockdown or inhibitor treatment in HeLa or MCF7 cells |
| RAD21 | Cohesinopathies; Cornelia de Lange syndrome | Knock-in of patient mutations in iPSCs; differentiation assays |
| RUNX1 | Leukemia; cohesin-dependent regulation | Knockout in hematopoietic stem cells; gene expression profiling |
Cancer and Aneuploidy
Dysregulation of positive regulation of mitotic sister chromatid separation leads to aneuploidy, a common feature of cancer. In BCR-ABL-positive leukemia cells, imatinib treatment increases separase proteolytic activity, linking targeted therapy to mitotic regulation. SPAG5, a regulator of chromosome segregation, is overexpressed in multiple cancers and serves as an immunological and prognostic biomarker. PLK1 is frequently overexpressed in tumors and is a target for small-molecule inhibitors. These findings underscore the importance of this GO term in cancer biology.
Cohesinopathies and Developmental Disorders
Mutations in cohesin subunits or regulators can cause developmental disorders known as cohesinopathies, such as Cornelia de Lange syndrome. Cohesin-dependent regulation of Runx genes affects differentiation and development, and disruption of this regulation may contribute to disease. Proper positive regulation of sister chromatid separation is essential for normal development, and its impairment can lead to chromosomal instability and congenital abnormalities.
Therapeutic Targeting of Mitotic Regulators
Because positive regulators of sister chromatid separation are often overexpressed in cancer, they represent attractive therapeutic targets. PLK1 inhibitors, separase inhibitors, and agents that interfere with cohesin dynamics are under investigation. In BCR-ABL-positive leukemia, imatinib modulates separase activity, suggesting that combining kinase inhibitors with mitotic regulators could improve outcomes. Understanding the precise mechanisms of positive regulation can guide the development of novel anticancer strategies.
From positive regulation of mitotic sister chromatid separation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ESPL1 block sister chromatid separation? | ESPL1 knockout cell line (e.g., HCT116) with live-cell imaging |
| Does a specific phosphorylation site on separase regulate its activity? | Point-mutation knock-in of phospho-deficient or phospho-mimetic ESPL1 |
| Does overexpression of PLK1 accelerate separation? | PLK1 overexpression in HeLa cells; time-lapse microscopy |
| Does a cancer-associated mutation in RAD21 affect cohesin cleavage? | Knock-in of RAD21 mutation in iPSCs; chromosome segregation assays |
| Can SPAG5 serve as a biomarker for drug response? | SPAG5 knockout and overexpression in cancer cell lines; drug sensitivity testing |
| How does imatinib affect separase activity in leukemia? | BCR-ABL-positive cell line (e.g., K562) treated with imatinib; separase activity assay |
How to Study the positive regulation of mitotic sister chromatid separation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Dynamics of sister chromatid separation | Assess effects of gene knockout or overexpression |
| Phosphoproteomics | Phosphorylation sites on mitotic proteins | Map signaling pathways regulating separase |
| Chromosome spreads | Cohesion status and aneuploidy | Validate separation defects in mutant cells |
| CRISPR knockout screens | Genes required for chromosome segregation | Identify novel positive regulators |
| Separase activity assay | Proteolytic cleavage of cohesin | Measure effects of drugs or mutations |
| RNA-seq | Transcriptional changes upon perturbation | Assess downstream effects of regulators |
| Proximity ligation assay | Protein-protein interactions in situ | Detect separase-cohesin interactions |
| Flow cytometry | Cell cycle profile and DNA content | Quantify aneuploidy and cell cycle arrest |
Live-Cell Imaging of Chromosome Dynamics
Live-cell imaging using fluorescently tagged histones (e.g., H2B-GFP) and kinetochore proteins allows direct visualization of sister chromatid separation in real time. This method can quantify the timing and frequency of separation events in cells with genetic perturbations. It is particularly useful for assessing the effects of knockout or overexpression of positive regulators such as separase or PLK1.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can identify phosphorylation sites on separase, cohesin subunits, and other mitotic regulators. This approach helps map the signaling networks that positively regulate sister chromatid separation. Quantitative phosphoproteomics after Cdk1 inhibition or PLK1 knockdown can reveal substrate relationships.
Chromosome Spreads and FISH
Chromosome spreads combined with fluorescence in situ hybridization (FISH) can detect premature sister chromatid separation or aneuploidy in cells with altered expression of regulators. This classical cytogenetic method provides a snapshot of chromosome cohesion status. It is often used to validate findings from live-cell imaging.
CRISPR Screens for Regulators
Genome-wide CRISPR knockout or activation screens can identify novel positive regulators of sister chromatid separation. By selecting for cells that survive or die under conditions that challenge chromosome segregation (e.g., spindle poisons), researchers can uncover genes that modulate this process. Such screens have implicated SPAG5 and other mitotic genes in cancer cell fitness.
How CRISPR Can Be Used to Study GO:1901970 positive regulation of mitotic sister chromatid separation
Knockout
CRISPR knockout of positive regulators such as ESPL1 or PLK1 can abolish or delay sister chromatid separation, leading to cell cycle arrest or apoptosis. These models are essential to establish causality and to study downstream effects on chromosome stability. Knockout cell lines can be generated in various cancer backgrounds to assess context-specific roles.
Point Mutation
Point mutations can be introduced into genes like ESPL1 to mimic or abolish phosphorylation sites, allowing precise dissection of regulatory mechanisms. For example, phospho-deficient or phospho-mimetic mutants of separase can reveal how Cdk1-cyclin B1 phosphorylation affects its activity. Such models are valuable for understanding the dual regulation of separase.
Knock-in
Knock-in of tagged versions of separase or cohesin subunits (e.g., GFP or HA tags) enables live-cell imaging and biochemical purification. Knock-in of disease-associated mutations in RAD21 or other cohesin genes can model cohesinopathies and reveal effects on sister chromatid separation. These models are crucial for linking genotype to phenotype.
Overexpression
Overexpression of positive regulators such as PLK1 or SPAG5 can accelerate or deregulate sister chromatid separation, potentially promoting aneuploidy and tumorigenesis. Overexpression models are used to study oncogenic roles and to test targeted therapies. They complement knockout studies by providing gain-of-function insights.
How EDITGENE Supports positive regulation of mitotic sister chromatid separation Research
Researchers studying positive regulation of mitotic sister chromatid separation-related genes often need to determine whether a candidate gene is causally involved in the process, and to dissect the precise molecular mechanisms. EDITGENE provides a comprehensive suite of CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support, enabling rigorous functional studies of this critical mitotic pathway.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of mitotic sister chromatid separation research.
Frequently Asked Questions About positive regulation of mitotic sister chromatid separation
What is GO:1901970?
GO:1901970 is the Gene Ontology term for positive regulation of mitotic sister chromatid separation, defined as any process that activates or increases the frequency, rate or extent of mitotic sister chromatid separation.
What genes are involved in positive regulation of mitotic sister chromatid separation?
Key genes include ESPL1 (separase), PLK1, CDK1, CCNB1, RAD21, WAPL, and SPAG5, among others.
How is sister chromatid separation positively regulated?
It is positively regulated by phosphorylation of separase by Cdk1-cyclin B1 and PLK1, degradation of securin by APC/C, and activation of the cohesin-releasing network.
Why is positive regulation of mitotic sister chromatid separation important?
It ensures faithful chromosome segregation and prevents aneuploidy; its dysregulation is linked to cancer and developmental disorders.
What diseases are associated with defects in this process?
Cancers such as BCR-ABL-positive leukemia and multiple solid tumors, as well as cohesinopathies like Cornelia de Lange syndrome.
How can CRISPR be used to study this process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to dissect the causal roles of specific genes in sister chromatid separation.
What methods are used to study positive regulation of mitotic sister chromatid separation?
Live-cell imaging, phosphoproteomics, chromosome spreads, and CRISPR screens are commonly used.
What is the role of separase in sister chromatid separation?
Separase is a protease that cleaves the cohesin subunit Rad21, allowing sister chromatids to separate; its activity is positively regulated by phosphorylation.
How does PLK1 regulate sister chromatid separation?
PLK1 phosphorylates securin and other mitotic substrates, promoting separase activation and cohesin removal.
What model systems are available to study this GO term?
Knockout, point-mutation, knock-in, and overexpression cell lines, as well as CRISPR library screens, are available from EDITGENE.
Conclusion
Positive regulation of mitotic sister chromatid separation (GO:1901970) is a tightly controlled biological process essential for genome stability. Its core mechanisms involve phosphorylation-dependent activation of separase, degradation of securin, and the cohesin-releasing network. Dysregulation of these events contributes to aneuploidy and cancer, making them attractive therapeutic targets. CRISPR-based models and advanced screening methods are powerful tools to further dissect this process and identify new regulatory components. EDITGENE offers comprehensive services to support such research, from knockout and knock-in cell lines to library screening and bioinformatics.
References
- 1. Horsfield JA et al.. 2007. Cohesin-dependent regulation of Runx genes.. Development 134(14):2639-49 PMID: 17567667
- 2. Shintomi K et al.. 2010. Sister chromatid resolution: a cohesin releasing network and beyond.. Chromosoma 119(5):459-67 PMID: 20352243
- 3. Hellmuth S et al.. 2015. Positive and negative regulation of vertebrate separase by Cdk1-cyclin B1 may explain why securin is dispensable.. J Biol Chem 290(12):8002-10 PMID: 25659430
- 4. Gao X et al.. 2023. Pan-cancer analysis: SPAG5 is an immunological and prognostic biomarker for multiple cancers.. FASEB J 37(10):e23159 PMID: 37650687
- 5. Liu J et al.. 2005. Xenopus Polo-like kinase Plx1: a multifunctional mitotic kinase.. Oncogene 24(2):238-47 PMID: 15640839
- 6. Brownlow N et al.. 2014. Mitotic catenation is monitored and resolved by a PKCε-regulated pathway.. Nat Commun 5:5685 PMID: 25483024
- 7. Haaß W et al.. 2012. The proteolytic activity of separase in BCR-ABL-positive cells is increased by imatinib.. PLoS One 7(8):e42863 PMID: 22870341
- 8. Heo SJ et al.. 1999. The budding yeast cohesin gene SCC1/MCD1/RHC21 genetically interacts with PKA, CDK and APC.. Curr Genet 36(6):329-38 PMID: 10654086
